Peripheral Arterial Disease (PAD) Treatment Devices

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD).

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the...

GE Healthcare showcased a new suite of connected cardiovascular technologies, including several for advanced imaging and new software capabilities, at ACC 2014...
FDA Abbott Supera Self-Expanding Stent Peripheral Artery Disease
The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused...
The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the...
Cordis Trieme Chocolate PTA Balloon Catheter Peripheral Artery Disease PAD
Cordis Corp. announced an agreement with TriReme Medical Inc. that grants the company exclusive distribution rights for the Chocolate PTA Balloon Catheter....
Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) are for the treatment of peripheral
Boston Scientific's OffRoad Re-Entry Catheter System treats complete arterial blockages in the major arteries of the legs. ...
AtheroMed's Phoenix Atherectomy System. This system allows physicians to treat peripheral artery disease (PAD) with a low...
Cordis Corp. is offering additional sizes of its Sleek OTW (over-the-wire) platform, a 0.014-inch ultra-low profile percutaneous...

Articles

bard, DEB, drug eluting balloon
The first clinical trial in the United States to study the use of drug-coated balloons (DCB) for femoropopliteal artery disease ...
August 28, 2013 — Effective Oct. 1, Cook Medical’s Zilver PTX drug-eluting peripheral stent qualifies for new-technology add-on payments under Medicare’s...
At the opening session of the third annual Amputation Prevention Symposium (AMP) in Chicago, Mary L. Yost, president of The Sage Group, delivered a...
January 31, 2013 — Cardiovascular Systems Inc. (CSI) announced CONFIRM study series data presented at the 2013 International Symposium on Endovascular Therapy...

Video Center

By Dave Fornell The biggest news item from the American College of Cardiology (ACC) 63rd Annual...
1 week 4 days ago
By Dave Fornell, DAIC editor Data from several cutting-edge device clinical trials will be...
3 weeks 4 days ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
4 weeks 4 days ago
The webinar will focus on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It will...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
CVIS, cardiovascular information system
This webinar reviews multi-ology, multi-site, vendor neutral solutions that transform rigid departmental information silos into fluid, consolidated, information sharing systems. It discusses how to...

Comparison Charts

Sorry there is no data available